Overview

Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the Aridol (mannitol) challenge test can predict response to treatment with inhaled corticosteroids in COPD subjects. Subjects will undergo an Aridol test and then 3 months of treatment with inhaled corticosteroids. The effect on lung function and quality of life will then be measured and correlated with the Aridol test result.
Phase:
Phase 2
Details
Lead Sponsor:
Pharmaxis
Treatments:
Albuterol
Bromides
Budesonide
Ipratropium
Mannitol